Source: Journal of thrombosis and thrombolysis. Unidade: FM
Subjects: DOENÇA DE VON WILLEBRAND, MIELOMA MÚLTIPLO
ABNT
SALDANHA, Artur et al. Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib. Journal of thrombosis and thrombolysis, v. 55, n. 4, p. 770-774, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53774. Acesso em: 07 nov. 2024.APA
Saldanha, A., Veiga, M. E., Okazaki, E., Rothschild, C., Martinez, G., Rocha, V. G., et al. (2023). Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib. Journal of thrombosis and thrombolysis, 55( 4), 770-774. doi:10.1007/s11239-023-02799-6NLM
Saldanha A, Veiga ME, Okazaki E, Rothschild C, Martinez G, Rocha VG, Orsi FA, Villaca P. Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib [Internet]. Journal of thrombosis and thrombolysis. 2023 ; 55( 4): 770-774.[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53774Vancouver
Saldanha A, Veiga ME, Okazaki E, Rothschild C, Martinez G, Rocha VG, Orsi FA, Villaca P. Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib [Internet]. Journal of thrombosis and thrombolysis. 2023 ; 55( 4): 770-774.[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53774